Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

ClinicalTrials.gov ID: NCT00364351

Public ClinicalTrials.gov record NCT00364351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, International, Randomised, Double Blind, Parallel-Group Study to Assess the Efficacy of Zactima™ Versus Tarceva® in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Failure of at Least One Prior Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine if ZD6474 a new investigational drug, is effective in treating Non Small Lung Cancer and if so, how it compares with another type of anti cancer therapy chemotherapy, Erlotinib

Study identification

NCT ID
NCT00364351
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
1,574 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2006
Primary completion
Aug 31, 2008
Completion
Oct 31, 2016
Last update posted
Jan 24, 2018

2006 – 2016

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Research Site Berkeley California
Research Site Los Angeles California
Research Site Santa Rosa California
Research Site Boynton Beach Florida
Research Site Fort Myers Florida
Research Site Jacksonville Florida
Research Site Port Saint Lucie Florida
Research Site Wichita Kansas
Research Site Lexington Kentucky
Research Site Louisville Kentucky
Research Site Metairie Louisiana
Research Site Baltimore Maryland
Research Site Columbia Missouri
Research Site St Louis Missouri
Research Site Latham New York
Research Site Hickory North Carolina
Research Site Canton Ohio
Research Site Cincinnati Ohio
Research Site Greenville South Carolina
Research Site Chattanooga Tennessee
Research Site Nashville Tennessee
Research Site Amarillo Texas
Research Site Garland Texas
Research Site Webster Texas
Research Site Fairfax Virginia
Research Site Norfolk Virginia
Research Site Richmond Virginia
Research Site Burien Washington
Research Site Yakima Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00364351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2018 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00364351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →